Tomosynthesis News and Research

RSS

KLAS announces 2013 Best in KLAS Awards for medical equipment and infrastructure

KLAS just released the 2013 Best in KLAS Awards: Medical Equipment & Infrastructure report ranking the best-performing imaging, pharmacy automation and infrastructure vendors in the world.

From Elekta 15 Jun 2013

Digital chest tomosynthesis holds promise as first-line screening tool for lung cancer

Most lung cancers are detected when patients become symptomatic and have late-stage disease. However, recently, computed tomography creening for lung cancer has been reported to reduce lung cancer mortality.

29 May 2013

3D mammography reduces unnecessary recalls, increases cancer detection

A recently published clinical study conducted at TOPS Comprehensive Breast Center in Houston, Texas, demonstrates that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls while simultaneously increasing cancer detection.

24 May 2013

Two views are necessary in 3D breast screening to ensure cancer is optimally visualized

One view 3D breast screening (tomosynthesis) means less radiation dose and about five seconds less compression, but a study from Yale University, New Haven, CT, found that obtaining both views is necessary to help ensure that a cancer won't be missed.

22 Apr 2013

2D plus 3D breast imaging could be useful in detecting cancer in women with dense breasts

2D plus 3D breast imaging increases cancer detection rates by 11%, and could be particularly useful in detecting cancer in women with dense breasts, a new study suggests.

19 Apr 2013

Tomosynthesis detects infiltrating ductal carcinoma in women at increased risk of breast cancer

Tomosynthesis (3D mammography) is better able to show infiltrating ductal carcinoma than 2D mammography in women at increased risk of breast cancer, a new study shows.

15 Apr 2013

Pros and cons of new screening technologies for breast cancer

Although mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, it has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term effects of repeated radiation.

8 Apr 2013

Researchers say breast cancer screening requires a personalized approach

Researchers at Moffitt Cancer Center predict that advancements in breast cancer screening will need a personalized touch because mammography is not a "one strategy fits all" technology.

5 Apr 2013

Tomosynthesis plus digital mammography improves cancer detection, reduces recall rates

Tomosynthesis imaging may improve breast cancer detection while reducing recall rates at mammographic screening, say researchers.

26 Nov 2012

FDR AcSelerate integrates Dual Energy Subtraction and Tomosynthesis

FDR AcSelerate, the fully automated positioning DR system from FUJIFILM Medical Systems U.S.A., Inc., will integrate two advanced applications to further extend diagnostic capabilities: Dual Energy Subtraction (DES) and Tomosynthesis (TS).

26 Nov 2012

Addition of tomosynthesis to standard mammogram increases breast screening accuracy

The addition of three-dimensional breast imaging-a technology called tomosynthesis-to standard digital mammography significantly increases radiologists' diagnostic accuracy while reducing false positive recall rates, according to the results of a multi-center study published in Radiology.

20 Nov 2012

MRS, Sectra partner to distribute MRS7 mammography tracking and reporting system

International medical technology company, Sectra, announces an agreement with Mammography Reporting System Inc. (MRS), a leading mammography tracking and reporting system provider, to distribute its solution, MRS7, fully integrated with Sectra Breast Imaging PACS.

2 Jun 2012

Digital breast tomosynthesis plus 2D mammography reduce patient recall rates by 40%

Adding digital breast tomosynthesis to 2D mammography screening results in a 40% reduction in patient recall rates compared to routine screening mammography alone, a new study shows.

3 May 2012

Hologic second quarter revenues increase 7.4% to $471.2 million

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the second fiscal quarter ended March 24, 2012.

From Hologic, Inc. 30 Apr 2012

New techniques show promise in detecting early-stage lung cancer

New techniques for identifying lung cancer earlier -including a new type of chest screening, a nanotech 'nose' and a method to examine the cells of the cheek-- are showing substantial promise, according to presentations at the 3rd European Lung Cancer Conference (ELCC) in Geneva.

19 Apr 2012

Tomosynthesis may be more beneficial in diagnosing knee OA than X-ray imaging

A recent study done by researchers at Boston University School of Medicine (BUSM) shows that tomosynthesis may be more beneficial in diagnosing knee osteoarthritis than X-ray imaging.

22 Mar 2012

Hologic first quarter revenues increase 9.3% to $472.7 million

From Hologic, Inc. 31 Jan 2012

Women & Infants the first to offer digital breast tomosynthesis in southeastern New England

There is still a one in eight lifetime risk that a woman will develop breast cancer, and the best tool against the disease remains early detection. Now, Women & infants Hospital of Rhode Island has taken the breast cancer battle to the next level with the installation of the most advanced imaging technology available, called digital breast tomosynthesis.

8 Dec 2011

Hologic releases C-View synthesized 2D image reconstruction algorithm

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the commercial release of its C-View synthesized 2D image reconstruction algorithm that eliminates the need for a conventional 2D mammogram as a component of a tomosynthesis (3D mammography) breast cancer screening exam.

From Hologic, Inc. 28 Nov 2011

Tomosynthesis offers women the next generation in breast cancer detection

Breast cancer is the second most common type of cancer among women in the United States, with approximately 200,000 new diagnoses each year. Early detection is key in the treatment of breast cancer and the biggest advancement for detection in 30 years has arrived at University Hospitals Case Medical Center - tomosynthesis, an innovative technology that provides three-dimensional detailed imaging of the breast.

1 Oct 2011